Kai Kraemer

1.0k total citations
21 papers, 829 citations indexed

About

Kai Kraemer is a scholar working on Molecular Biology, Surgery and Biomedical Engineering. According to data from OpenAlex, Kai Kraemer has authored 21 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Biomedical Engineering. Recurrent topics in Kai Kraemer's work include RNA Interference and Gene Delivery (7 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Cancer Research and Treatments (3 papers). Kai Kraemer is often cited by papers focused on RNA Interference and Gene Delivery (7 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Cancer Research and Treatments (3 papers). Kai Kraemer collaborates with scholars based in Germany, Poland and United States. Kai Kraemer's co-authors include Susanne Fuessel, Axel Meye, Manfred P. Wirth, U. Schmidt, Matthias Kotzsch, Carla Tripisciano, Arthur Taylor, E. Borowiak‐Palen, Bernd Schwenzer and Helge Täubert and has published in prestigious journals such as Oncogene, Chemical Physics Letters and The Journal of Urology.

In The Last Decade

Kai Kraemer

21 papers receiving 812 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Kraemer Germany 15 488 174 163 114 109 21 829
Yuyue Zhao China 15 246 0.5× 198 1.1× 47 0.3× 60 0.5× 57 0.5× 31 682
Fangyuan Xie China 20 362 0.7× 231 1.3× 114 0.7× 33 0.3× 24 0.2× 36 935
Junxiao Ye China 17 516 1.1× 176 1.0× 82 0.5× 31 0.3× 39 0.4× 23 864
Huining He China 19 573 1.2× 499 2.9× 135 0.8× 56 0.5× 42 0.4× 44 1.3k
Hans H. Riese Spain 10 350 0.7× 58 0.3× 37 0.2× 66 0.6× 68 0.6× 12 656
Matin Chehelgerdi Iran 5 398 0.8× 271 1.6× 111 0.7× 29 0.3× 30 0.3× 6 864
Yan Wei China 19 381 0.8× 296 1.7× 114 0.7× 48 0.4× 22 0.2× 28 866
Seung Woo Chung South Korea 20 493 1.0× 290 1.7× 105 0.6× 69 0.6× 19 0.2× 47 1.0k
Guoqiao Chen China 13 331 0.7× 212 1.2× 143 0.9× 43 0.4× 32 0.3× 29 724
Chang‐Cheng Liu China 16 1.1k 2.3× 128 0.7× 31 0.2× 343 3.0× 63 0.6× 42 1.4k

Countries citing papers authored by Kai Kraemer

Since Specialization
Citations

This map shows the geographic impact of Kai Kraemer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Kraemer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Kraemer more than expected).

Fields of papers citing papers by Kai Kraemer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Kraemer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Kraemer. The network helps show where Kai Kraemer may publish in the future.

Co-authorship network of co-authors of Kai Kraemer

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Kraemer. A scholar is included among the top collaborators of Kai Kraemer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Kraemer. Kai Kraemer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erdmann, Kati, Silke Hampel, Kai Kraemer, et al.. (2013). Carbon Nanofibers and Carbon Nanotubes Sensitize Prostate and Bladder Cancer Cells to Platinum-Based Chemotherapeutics. Journal of Biomedical Nanotechnology. 10(3). 463–477. 28 indexed citations
2.
Haase, Diana, Silke Hampel, Steffen Oswald, et al.. (2010). Delivery of carboplatin by carbon-based nanocontainers mediates increased cancer cell death. Nanotechnology. 21(33). 335101–335101. 56 indexed citations
3.
Cirillo, Giuseppe, Kai Kraemer, Susanne Fuessel, et al.. (2010). Biological Activity of a Gallic Acid−Gelatin Conjugate. Biomacromolecules. 11(12). 3309–3315. 69 indexed citations
4.
Tripisciano, Carla, Kai Kraemer, Arthur Taylor, & E. Borowiak‐Palen. (2009). Single-wall carbon nanotubes based anticancer drug delivery system. Chemical Physics Letters. 478(4-6). 200–205. 126 indexed citations
5.
Taylor, Arthur, Kai Kraemer, Silke Hampel, et al.. (2008). CARBON COATED NANOMAGNETS AS POTENTIAL HYPERTHERMIA AGENTS. The Journal of Urology. 179(4S). 392–393. 7 indexed citations
6.
Kunze, Doreen, Daniela Wuttig, Ingo Kausch, et al.. (2008). Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo. International Journal of Oncology. 32(5). 1049–56. 22 indexed citations
7.
Kunze, Doreen, Daniela Wuttig, Susanne Fuessel, et al.. (2008). Multitarget siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-X(L)) in bladder cancer cells.. PubMed. 28(4B). 2259–63. 25 indexed citations
8.
Kraemer, Kai, Susanne Fuessel, & Axel Meye. (2007). Telomerase Inhibition by Synthetic Nucleic Acids and Chemosensitization in Human Bladder Cancer Cell Lines. Methods in molecular biology. 405. 9–22. 5 indexed citations
9.
Fuessel, Susanne, Axel Meye, Kai Kraemer, et al.. (2006). Synthetic Nucleic Acids as Potential Therapeutic Tools for Treatment of Bladder Carcinoma. European Urology. 51(2). 315–327. 9 indexed citations
10.
Kraemer, Kai, U. Schmidt, Susanne Fuessel, et al.. (2006). Microarray analyses in bladder cancer cells: Inhibition of hTERT expression down‐regulates EGFR. International Journal of Cancer. 119(6). 1276–1284. 18 indexed citations
11.
Täubert, Helge, Thomas Greither, Deepak Kaushal, et al.. (2006). Expression of the stem cell self-renewal gene Hiwi and risk of tumour-related death in patients with soft-tissue sarcoma. Oncogene. 26(7). 1098–1100. 111 indexed citations
12.
Fuessel, Susanne, Matthias Kotzsch, Kai Kraemer, et al.. (2005). Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNA. Cancer Letters. 232(2). 243–254. 44 indexed citations
13.
Krause, Sabine, Yvonne Förster, Kai Kraemer, et al.. (2005). VASCULAR ENDOTHELIAL GROWTH FACTOR ANTISENSE PRETREATMENT OF BLADDER CANCER CELLS SIGNIFICANTLY ENHANCES THE CYTOTOXICITY OF MITOMYCIN C, GEMCITABINE AND CISPLATIN. The Journal of Urology. 174(1). 328–331. 17 indexed citations
14.
Fuessel, Susanne, Matthias Kotzsch, Kai Kraemer, et al.. (2004). siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth.. International Journal of Oncology. 25(4). 1065–1136. 59 indexed citations
15.
Schmidt, U., Susanne Fuessel, Michael Haase, et al.. (2004). Quantification of C13orf19/P38IP mRNA expression by quantitative real-time PCR in patients with urological malignancies. Cancer Letters. 225(2). 253–260. 7 indexed citations
16.
Kraemer, Kai, Susanne Fuessel, Matthias Kotzsch, et al.. (2004). CHEMOSENSITIZATION OF BLADDER CANCER CELL LINES BY HUMAN TELOMERASE REVERSE TRANSCRIPTASE ANTISENSE TREATMENT. The Journal of Urology. 172(5). 2023–2028. 31 indexed citations
17.
Kotzsch, Matthias, Kai Kraemer, Matthias Kappler, et al.. (2004). 203 Sirna-mediated down-regulation of survivin inhibits bladder cancer cell growth. European Urology Supplements. 3(2). 53–53. 11 indexed citations
18.
Fuessel, Susanne, Matthias Kotzsch, Kai Kraemer, et al.. (2004). 957: SiRNA-Mediated Down-Regulation of Survivin Inhibitsbladder Cancer Cell Growth. The Journal of Urology. 171(4S). 254–254. 21 indexed citations
19.
Schmidt, U., Udo Bilkenroth, C. Linné, et al.. (2004). Quantification of disseminated tumor cells in the bloodstream of patients with hormone-refractory prostate carcinoma undergoing cytotoxic chemotherapy.. PubMed. 24(6). 1393–9. 9 indexed citations
20.
Kraemer, Kai, Susanne Fuessel, U. Schmidt, et al.. (2003). Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells.. PubMed. 9(10 Pt 1). 3794–800. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuyue Zhao Breakdown of academic impact, for papers by Fangyuan Xie Breakdown of academic impact, for papers by Junxiao Ye Breakdown of academic impact, for papers by Huining He Breakdown of academic impact, for papers by Hans H. Riese Breakdown of academic impact, for papers by Matin Chehelgerdi Breakdown of academic impact, for papers by Yan Wei Breakdown of academic impact, for papers by Seung Woo Chung Breakdown of academic impact, for papers by Guoqiao Chen Breakdown of academic impact, for papers by Chang‐Cheng Liu
Rankless by CCL
2026